Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050618 · ClinicalTrials.gov registry record · NA
Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT04050618 is a NA study that has completed, run by CooperVision. The registered enrollment target is 114 participants.
The verdict
NCT04050618, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
To evaluate the comparative clinical performance of the fanfilcon A silicone hydrogel lens used in daily wear and to compare this with competitive hydrogel lens products.
Interventions
- DEVICE fanfilcon A test lens
- DEVICE ocufilcon D control lens
- DEVICE etafilcon A control lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2019-06-09 |
| Est. Completion | 2019-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04050618
The ClinicalTrials.gov registry entry for NCT04050618 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fanfilcon A test lens is the first listed.
NCT04050618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04050618 about?
NCT04050618 is a clinical study titled "Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear". To evaluate the comparative clinical performance of the fanfilcon A silicone hydrogel lens used in daily wear and to compare this with competitive hydrogel lens products.
What is the current status of trial NCT04050618?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2019-06-09. Estimated completion is 2019-11-08.
What interventions are being tested in trial NCT04050618?
The interventions under investigation include: fanfilcon A test lens (DEVICE), ocufilcon D control lens (DEVICE), etafilcon A control lens (DEVICE).
Who is sponsoring clinical trial NCT04050618?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.